Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma

International Journal of Cancer

Volumn 84, Issue 4, 1999, Pages 410-415

  Blons, Hélène ^a   Cabelguenne, Arnauld ^a   Carnot, Françoise ^b   Laccourreye, Ollivier ^c   De Waziers, Isabelle ^a   Hamelin, Richard ^d   Brasnu, Daniel ^c   Beaune, Philippe ^a   Laurent Puig, Pierre ^a,c  

^a INSERM   (France)

^b University of Paris Diderot   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; FEMALE; GENETIC ANALYSIS; HEAD CANCER; HETEROZYGOSITY LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NECK CANCER; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 0032784924     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990820)84:4<410::AID-IJC14>3.0.CO;2-J     Document Type: Article

References (27)

1. AEBI, S., KURDI-HAIDAR, B., GORDON, R., CENNI, B., ZHENG, H., FINK, D., CHRISTEN, R.D., RICHARD-BOLAND, C., KOI, M., FISHEL, R. and HOWELL, S.B., Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res., 56, 3087-3090 (1996).
2. AH-SEE, K.W., COOKE, T.G., PICKFORD, I.R., SOUTAR, D. and BALMAIN, A., An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res., 54, 1617-1621 (1994).
3. AL-SARRAF, M., LEBLANC, M., GIRI, P.G., FU, K.K., COOPER, J., VUONG, T., FORASTIERE. A.A., ADAMS, G., SAKR, W.A., SCHULLER, D.E. and ENSLEY, J.F., Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J. clin. Oncol., 16, 1310-1317 (1998).
4. ANTHONEY, D.A., MCILWRATH, A.J., GALLAGHER, W.M., EDLIN, A.R. and BROWN, R., Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res., 56, 1374-1381 (1996).
5. BOCKMÜHL, U., PERTERSEN, S., SCHMIDT, S., WOLF, G., JAHNKE, W., DIETEL, M. and PERTERSEN, I., Patterns of chromosomal alterations in metastasizing and non-metastasizing primary head and neck carcinomas. Cancer Res., 57, 5213-5216 (1997).
6. BOLAND, R., THIBODEAU, S.N., HAMILTON, S.R., SIDRANSKY, D., ESHLEMAN, J.R., BURT, R.W., MELTZER, S.J., RODRIGUEZ-BIGAS, M., FODDE, R., RANZANI, G.N. and SRIVASTAVA, S., A National Cancer institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58, 5248-5257 (1998).
7. BRANCH, O., AQUILINA, G., BIGNAMI, M. and KARRAN, P., Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature (Lond.), 362, 652-654 (1993).
8. BUBB, V.J., CURTIS, L.J., CUNNINGHAM, C., DUNLOP, M.G., CAROTHERS, A.D., MORRIS, R.G., WHITE, S., BIRD, C.C. and WYLLIE, A.H., Microsatelite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene, 12, 2641-2649 (1996).
9. CALIFANO, J., VAN DER REIT, P., WESTRA, W., NAWROZ, H., CLAYMAN, G., PIANTADOSI, S., CORIO, R., LEE, D., GREENBERG, B., KOCH, W. and SIDRANSKY, D., Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56, 2488-2492 (1996).
10. CATINEL, G., Head and neck cancer; guidelines for chemotherapy. Drugs, 51, 73-88 (1996).
11. DEPARTMENT OF VETERANS AFFAIRS LARYNGEAL CANCER STUDY GROUP, Induction chemotherapy plus radiation compared with surgery in patients with advanced laryngeal cancer. N. Engl. J. Med., 324, 1635-1690 (1991).
12. EL-NAGGAR, A.K., HURR, K., HUFF, V., CLAYMAN, G.L., LUNA, M.A. and BATSAKIS, J.G., Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. Amer. J. Pathol., 148, 2072-2097 (1996).
13. FIELD, J.K., KIARIS, H., HOWARD, P., VAUGHAN, E.D., SPANDIDOS, D.A. and JONES, A.S., Microsatellite instability in squamous cell carcinoma of the head and neck. Brit. J. Cancer, 71, 1065-1069 (1995a).
14. FIELD, J.K. and 15 OTHERS, Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Brit. J. Cancer, 72, 1180-1188 (1995b).
15. FINK, D., NEBEL, S., AEBI, S., ZHENG, H., CENNI, B., NEHMI, A., CHRISTEN, R.D. and HOWEL, S.B., Role of DNA mismatch repair in platinum drug resistance. Cancer Res., 56, 4881-4886 (1996).
16. FINK, D., ZHENG, H., NEBEL, S., NORIS, P.S., AEBI, S., LIN, T.P., NEHMÉ, A., CHRISTEN, R.D., HAAS, M., MACLEOD, C. and HOWELL, S.B., In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res., 57, 1841-1845 (1997).
17. GLEESON, C.M., SLOAN, J.M., MCGUIGAN, J.A., RITCHIE, A.J., WEBER, J.L. and RUSSELL, S.E., Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia. Oncogene, 12, 1653-1662 (1996).
18. LACCOURREYE, O., BRASNU, D., BASSOT, V., MENARD, M., KHAYAT, D. and LACCOURREYE, H., Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results. J. clin. Oncol., 14, 2331-2336 (1996).
19. LOUHELAINEN, J., SZYFTER, K., SZYFTER, W. and HEMMINKI, K., Loss of heterozygosity and microsatellite instability in larynx cancer. Int. J. Oncol., 10, 247-252 (1997).
20. LOWE, S.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967 (1993).
21. LYNCH, H.T. and SMYRK, T., Hereditary non-polyposis colorectal cancer (Lynch syndrome). An updated review. Cancer, 78, 1149-1167 (1996).
22. NAGAO, M., WAKABAYASHI, K., USHIJIMA, T., TOYOTA, M., TOTSUKA, Y. and SUGIMURA, T., Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals. Environ. Health Perspect., 104, 497-501 (1996).
23. NAWROZ, H., VAN DER RIET, P., HURBAN, R.H., KOCH, W., RUPPERT, J.M. and SIDRANSKY, D., Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54, 1152-1155 (1994).
24. OLSCHWANG, S., HAMELIN, R., LAURENT-PUIG, P., THUILLE, B., DE RYCKE, Y., LI, Y.J., MUZEAU, F., GIRODET, J., SALMON, R.J. and THOMAS, G., Alternative genetic pathways in colorectal carcinogenesis. Proc. nat. Acad. Sci. (Wash.), 94, 12122-12127 (1997).
25. PARKIN, D.M., LAARA, E. and MUIR, C.S., Estimates of the worldwide frequency of the 16 major cancers in the 1980s. Int. J. Cancer, 41, 184-187 (1988).
26. PEARLSTEIN, R.P., BENNINGER, M.S., CAREY, T.E., ZARBO, R.J., TORRES, F.X., RYBICKI, B.A. and DYKE, D.L., Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer. 21, 333-339 (1998).
27. ZHOU, X.P. and 14 OTHERS, Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer, 21, 101-107 (1998).